Advances in pharmacological treatment for acute respiratory distress syndrome
10.3760/cma.j.issn.1008-6706.2019.21.029
- VernacularTitle: 急性呼吸窘迫综合征药物治疗的研究进展
- Author:
Kexiang ZHANG
1
;
Qilong ZHOU
;
Chao LIU
Author Information
1. Department of Critical Care Medicine, Three Gorges Center Hospital of Chongqing, Chongqing 404000, China
- Publication Type:Journal Article
- Keywords:
Respiratory distress syndrome, adult;
Drug therapy;
Glucocorticoids;
Cystatins;
Antioxidants;
Pulmonary surfactant-associated proteins;
Mesenchymal stem cells;
Vasodilator agents;
Review
- From:
Chinese Journal of Primary Medicine and Pharmacy
2019;26(21):2685-2688
- CountryChina
- Language:Chinese
-
Abstract:
Acute respiratory distress syndrome(ARDS) is a common critical syndrome with high morbidity and mortality.The treatments include respiratory support and drug therapy.In this paper, the latest clinical advances in the treatment of ARDS with glucocorticoids, statins, antioxidants, recombinant human activated protein C, sedatives and muscle relaxants, exogenous alveolar surfactants, mesenchymal stem cells, and vasodilators are reviewed.
